This trial is active, not recruiting.

Conditions asystole, sinus bradycardia, sinus tachycardia, sinus arrhythmia, atril fibrillation
Sponsor Taipei Medical University WanFang Hospital
Start date July 2010
End date September 2010
Trial size 380 participants
Trial identifier NCT01200667, 0990004864


The application scenario is shown in the figure below: the user utilizes an ECG-based wireless sensor (WiBoC Chipset), and transmit those signals to a mobile-phone device that has an embedded expert system integrated. With the aid of 3G system, a remote healthcare monitoring center receives those uploaded signals and stores into the application server. According to the events from this server, the people on service responses to the emergency and takes the corresponding process.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective cross-sectional

Eligibility Criteria

Male or female participants at least 20 years old.

Inclusion Criteria: - Emergency patient with chest pain. - Emergency patients were implementation of 12-lead EKG during observation. - Out-patient services of Cardiology with arrhythmia history. - Adults over 20 years old. Exclusion Criteria: - The patient required the intervention of resuscitation and cardiac massage. - Chest trauma - On pacemaker

Additional Information

Official title uPHI: Wireless Body Area Network Core Technology
Principal investigator Ray-Jade Chen
Trial information was received from ClinicalTrials.gov and was last updated in September 2010.
Information provided to ClinicalTrials.gov by Taipei Medical University WanFang Hospital.